These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 33161283)

  • 1. Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study.
    Hardy M; Michaux I; Lessire S; Douxfils J; Dogné JM; Bareille M; Horlait G; Bulpa P; Chapelle C; Laporte S; Testa S; Jacqmin H; Lecompte T; Dive A; Mullier F
    Thromb Res; 2021 Jan; 197():20-23. PubMed ID: 33161283
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
    White D; MacDonald S; Edwards T; Bridgeman C; Hayman M; Sharp M; Cox-Morton S; Duff E; Mahajan S; Moore C; Kirk M; Williams R; Besser M; Thomas W
    Int J Lab Hematol; 2021 Feb; 43(1):123-130. PubMed ID: 32892505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19-related laboratory coagulation findings.
    Devreese KMJ
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):36-42. PubMed ID: 34288440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock.
    Andersen MG; Hvas CL; Tønnesen E; Hvas AM
    Acta Anaesthesiol Scand; 2014 May; 58(5):525-33. PubMed ID: 24580049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19).
    Arachchillage DRJ; Shi C; Saliu D; Kozman P; Mi E; Buti N; Kashef E; Copley SJ; Gomez C; Leonard R; Aziz R; Shlebak AA; Laffan M
    Semin Thromb Hemost; 2021 Jun; 47(4):436-441. PubMed ID: 33482676
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.
    Schulman S
    Semin Thromb Hemost; 2020 Oct; 46(7):772-776. PubMed ID: 32392613
    [No Abstract]   [Full Text] [Related]  

  • 7. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
    Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
    Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis.
    Radenković D; Bajec D; Karamarkovic A; Stefanovic B; Milic N; Ignjatović S; Gregoric P; Milicevic M
    Pancreas; 2004 Aug; 29(2):152-6. PubMed ID: 15257107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematological findings and complications of COVID-19.
    Terpos E; Ntanasis-Stathopoulos I; Elalamy I; Kastritis E; Sergentanis TN; Politou M; Psaltopoulou T; Gerotziafas G; Dimopoulos MA
    Am J Hematol; 2020 Jul; 95(7):834-847. PubMed ID: 32282949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
    Asakura H; Ogawa H
    Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
    Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic System (Fibrinogen Level, D-Dimer, and FDP) in Severe and Non-Severe Patients With COVID-19: A Systematic Review and Meta-Analysis.
    Rostami M; Khoshnegah Z; Mansouritorghabeh H
    Clin Appl Thromb Hemost; 2021; 27():10760296211010973. PubMed ID: 34933579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II.
    Favaloro EJ; Lippi G
    Semin Thromb Hemost; 2021 Jun; 47(4):333-337. PubMed ID: 34062596
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19).
    Henry BM; Benoit SW; Hoehn J; Lippi G; Favaloro EJ; Benoit JL
    Semin Thromb Hemost; 2020 Oct; 46(7):859-862. PubMed ID: 32882718
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased resistance to fibrinolysis activation in patients with coronavirus disease 2019: a case series.
    Duque P; Chasco-Ganuza M; Burgos-Santamaria A; Terradillos E
    Blood Coagul Fibrinolysis; 2021 Jun; 32(4):298-301. PubMed ID: 33491994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis.
    Nougier C; Benoit R; Simon M; Desmurs-Clavel H; Marcotte G; Argaud L; David JS; Bonnet A; Negrier C; Dargaud Y
    J Thromb Haemost; 2020 Sep; 18(9):2215-2219. PubMed ID: 32668058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case-control study.
    De Cristofaro R; Liuzzo G; Sacco M; Lancellotti S; Pedicino D; Andreotti F
    Blood Coagul Fibrinolysis; 2021 Jun; 32(4):285-289. PubMed ID: 33443926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-dimer Level and Diabetes in the COVID-19 Infection.
    Miri C; Charii H; Bouazzaoui MA; Laouan Brem F; Boulouiz S; Abda N; Kouismi H; Bazid Z; Ismaili N; El Ouafi N
    Clin Appl Thromb Hemost; 2021; 27():10760296211045902. PubMed ID: 34590493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
    Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G
    Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.